Showing 2716 results
-
Press Release /Entresto is the first and only therapy approved in the US to treat patients diagnosed with guideline-defined heart failure to include both those with heart failure with reduced ejection fraction (…
-
Statement /
-
Story /Novartis researchers are collaborating with tech startup PathAI to search for hidden information in pathology slides.
-
Media Library / -
Statement /
-
Media Library / -
Media Library / -
Media Library / -
Press Release /New approvals are based on JUNIPERA trial data showing Cosentyx® (secukinumab) demonstrated reduced flare risk versus placebo and improvement in disease activity observed over two years across both…
-
Key Release /Ad hoc announcement pursuant to Art. 53 LR With two maintenance doses a year, Leqvio is the first and only FDA-approved small interfering RNA (siRNA) therapy for LDL-C (bad cholesterol…